| 1. |
Ulrich SD, Seyler TM, Bennett D, Delanois RE, Saleh KJ, Thongtrangan I, et al. Total hip arthroplasties: What are the reasons for revision? Int Orthop 2008;32:597-604.
|
| 2. |
Jafari SM, Coyle C, Mortazavi SM, Sharkey PF, Parvizi J. Revision hip arthroplasty: Infection is the most common cause of failure. Clin Orthop Relat Res 2010;468:2046-51.
|
| 3. |
Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty 2009;24:105-9.
|
| 4. |
Shahi A, Kheir MM, Tarabichi M, Hosseinzadeh HR, Tan TL, Parvizi J. Serum D-dimer test is promising for the diagnosis of periprosthetic joint infection and timing of reimplantation. J Bone Joint Surg Am 2017;99:1419-27.
|
| 5. |
Piper KE, Fernandez-Sampedro M, Steckelberg KE, Mandrekar JN, Karau MJ, Steckelberg JM, et al. C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infection. PLoS One 2010;5:e9358.
|
| 6. |
Michelin E, Snijders D, Conte S, Dalla Via P, Tagliaferro T, Da Dalt L, et al. Procoagulant activity in children with community acquired pneumonia, pleural effusion and empyema. Pediatr Pulmonol 2008;43:472-5.
|
| 7. |
Jhan SW, Lu YD, Lee MS, Lee CH, Wang JW, Kuo FC. The risk factors of failed reimplantation arthroplasty for periprosthetic hip infection. BMC Musculoskelet Disord 2017;18:255.
|
| 8. |
Fan SL, Miller NS, Lee J, Remick DG. Diagnosing sepsis – The role of laboratory medicine. Clin Chim Acta 2016;460:203-10.
|
| 9. |
Ugarte H, Silva E, Mercan D, de Mendonça A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999;27:498-504.
|
| 10. |
Reny JL, Vuagnat A, Ract C, Benoit MO, Safar M, Fagon JY. Diagnosis and follow-up of infections in intensive care patients: Value of C-reactive protein compared with other clinical and biological variables. Crit Care Med 2002;30:529-35.
|
| 11. |
Póvoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2005;11:101-8.
|
| 12. |
Póvoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, et al. Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: A prospective observational study. Crit Care 2006;10:R63.
|
| 13. |
Prucha M, Bellingan G, Zazula R. Sepsis biomarkers. Clin Chim Acta 2015;440:97-103.
|
| 14. |
Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care 2004;8:R82-90.
|
| 15. |
Cicala C, Cirino G. Linkage between inflammation and coagulation: An update on the molecular basis of the crosstalk. Life Sci 1998;62:1817-24.
|
| 16. |
Cirino G, Cicala C, Bucci MR, Sorrentino L, Maraganore JM, Stone SR. Thrombin functions as an inflammatory mediator through activation of its receptor. J Exp Med 1996;183:821-7.
|
| 17. |
Contrino J, Goralnick S, Qi J, Hair G, Rickles FR, Kreutzer DL. Fibrin induction of tissue factor expression in human vascular endothelial cells. Circulation 1997;96:605-13.
|
| 18. |
Kitching AR, Holdsworth SR, Ploplis VA, Plow EF, Collen D, Carmeliet P, et al. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 1997;185:963-8.
|
| 19. |
Schuster V, Seidenspinner S, Zeitler P, Escher C, Pleyer U, Bernauer W, et al. Compound-heterozygous mutations in the plasminogen gene predispose to the development of ligneous conjunctivitis. Blood 1999;93:3457-66.
|
| 20. |
Perez RL, Roman J. Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation. J Immunol 1995;154:1879-87.
|
| 21. |
Ribera T, Monreal L, Armengou L, Ríos J, Prades M. Synovial fluid D-dimer concentration in foals with septic joint disease. J Vet Intern Med 2011;25:1113-7.
|